Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
58,228,856
-
Share change
-
+1,947,174
-
Total reported value
-
$458,218,605
-
Put/Call ratio
-
159%
-
Price per share
-
$7.87
-
Number of holders
-
125
-
Value change
-
+$9,215,236
-
Number of buys
-
63
-
Number of sells
-
61
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2018
As of 31 Dec 2018 CYMABAY THERAPEUTICS INC - COM (CBAY) had 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 58,228,856 shares of stock of the company.
Largest 10 holders included BlackRock Inc., BAKER BROS. ADVISORS LP, Redmile Group, LLC, Vanguard Group Inc, EAGLE ASSET MANAGEMENT INC, Foresite Capital Management IV, LLC, PERCEPTIVE ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BOXER CAPITAL, LLC, and CARILLON TOWER ADVISERS, INC..
This table shows 125 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.